Valuation: Ipsen

Market Cap 13.86B 15.84B 12.78B 11.81B 22.4B 1,511B 22.78B 153B 59.98B 744B 59.49B 58.19B 2,559B P/E 2026 *
15.3x
P/E 2027 * 15.1x
Enterprise Value 12.43B 14.21B 11.47B 10.59B 20.1B 1,356B 20.43B 137B 53.81B 668B 53.37B 52.21B 2,296B EV / Sales 2026 *
2.91x
EV / Sales 2027 * 2.55x
Free-Float
40.65%
Yield 2026 *
0.89%
Yield 2027 * 0.89%
1 day-3.61%
1 week-4.69%
Current month-3.61%
1 month+4.90%
3 months-4.74%
6 months+25.83%
Current year+36.72%
1 week 161.4
Extreme 161.4
172.7
1 month 152.7
Extreme 152.7
172.7
Current year 116
Extreme 116
173.5
1 year 101.9
Extreme 101.9
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
06-01Fiscal year

Chief Executive Officer

-26,583 0.0317%
05-27Sell

Chief Executive Officer

-1,000 0.0012%
02-25Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-3.61%-4.69%+50.37%+49.68% 15.84B
-2.74%-1.02%+50.23%+162.11% 1,085B
-1.21%-1.25%+62.39%+60.54% 624B
-1.52%-3.39%+26.22%+83.00% 442B
+0.33%-1.17%+27.98%+26.90% 332B
-3.89%-11.22%+20.78%+26.07% 277B
-0.02%-2.85%+25.27%+44.88% 282B
+0.66%-1.42%-29.26%-39.30% 217B
-0.09%-0.84%+20.97%+61.69% 196B
-3.73%+0.37%+13.58%+71.87% 167B
Average -1.65%-1.81%+26.85%+54.74% 363.78B
Weighted average by Cap. -1.68%-1.06%+35.19%+81.24%

Financials

2026 *2027 *
Net sales 4.27B 4.88B 3.93B 3.63B 6.9B 465B 7.01B 47.01B 18.46B 229B 18.31B 17.91B 788B 4.48B 5.12B 4.13B 3.82B 7.24B 489B 7.37B 49.39B 19.39B 241B 19.24B 18.82B 827B
Net income 945M 1.08B 872M 805M 1.53B 103B 1.55B 10.42B 4.09B 50.76B 4.06B 3.97B 175B 947M 1.08B 874M 807M 1.53B 103B 1.56B 10.44B 4.1B 50.88B 4.07B 3.98B 175B
Net Debt -1.43B -1.63B -1.32B -1.21B -2.31B -155B -2.34B -15.72B -6.17B -76.6B -6.12B -5.99B -263B -2.43B -2.77B -2.24B -2.07B -3.92B -264B -3.99B -26.73B -10.5B -130B -10.41B -10.19B -448B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
10/07/26 162.70 -3.61% 103,718
09/07/26 €168.80 +1.69% 102,020
08/07/26 €166.00 -1.43% 140,827
07/07/26 €168.40 -0.65% 97,562
06/07/26 €169.50 -0.70% 80,079
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
168.80EUR
Average target price
161.33EUR
Spread / Average Target
-4.42%

Quarterly revenue - Rate of surprise